BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 27748023)

  • 1. Precision medicine in pediatric oncology: Lessons learned and next steps.
    Mody RJ; Prensner JR; Everett J; Parsons DW; Chinnaiyan AM
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27748023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in precision therapy in pediatric oncology.
    O'Donohue T; Farouk Sait S; Glade Bender J
    Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing Genome-Driven Oncology.
    Hyman DM; Taylor BS; Baselga J
    Cell; 2017 Feb; 168(4):584-599. PubMed ID: 28187282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AACR precision medicine series: Highlights of the integrating clinical genomics and cancer therapy meeting.
    Maggi E; Montagna C
    Mutat Res; 2015 Dec; 782():44-51. PubMed ID: 26554403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
    Surrey LF; Luo M; Chang F; Li MM
    Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular-Genetic Diagnosis and Molecular-Targeted Therapy in Cancer: Challenges in the Era of Precision Medicine].
    Miyachi H
    Rinsho Byori; 2015 Oct; 63(10):1188-93. PubMed ID: 26897855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Reverse-Phase Protein Array for Refining Precision Oncology.
    Masuda M; Yamada T
    Adv Exp Med Biol; 2019; 1188():239-249. PubMed ID: 31820392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
    Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
    Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of precision medicine in pediatric oncology in Spain: a consensus report by the Spanish Society of Paediatric Haematology and Oncology (SEHOP).
    Gargallo P; Bautista F; Juan-Ribelles A; Izquierdo E; Soriano A; de Rojas T; Escudero A; Lavarino C; Solano P; Hladun R; Rubio-San-Simón A; Martínez-Romera I; Calabria I; Olaciregui NG; Castañeda-Heredia A; de Álava E; Pérez-Martínez A; Astigarraga I; Patiño-García A; Alonso J; Fernández-Teijeiro A; Cañete A; Moreno L
    Clin Transl Oncol; 2022 May; 24(5):809-815. PubMed ID: 35152364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision diagnostics: integration of tissue pathology and genomics in cancer.
    Sharma S; George P; Waddell N
    Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
    Damodaran S; Berger MF; Roychowdhury S
    Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.